TY - JOUR
T1 - Effects of post-discharge management on rates of early re-admission and death after hospitalisation for heart failure
AU - Huynh, Quan
AU - Negishi, Kazuaki
AU - De Pasquale, Carmine
AU - Hare, James
AU - Leung, Dominic
AU - Stanton, Tony
AU - Marwick, Thomas H.
PY - 2018/6
Y1 - 2018/6
N2 - Objectives: To investigate whether enrolment of patients in management programs after hospitalisation for heart failure (HF) reduces the likelihood of post-hospital adverse outcomes. Design: Cohort study in which associations between adverse outcomes at 30 and 90 days for people hospitalised for HF and baseline clinical, socio-demographic and blood pathology factors, and with post-discharge management strategies, were assessed. Setting, participants: 906 patients with HF were prospectively enrolled in five Australian states at cardiology departments with expertise in treating people with HF. Main outcome measures: All-cause re-admissions and deaths at 30 and 90 days after discharge from the index admission. Results: 58% of patients were men; the mean age was 72.5 years (SD, 13.9 years). By hospital, 30-day re-admission rates ranged from 17% to 33%, and 90-day rates from 40% to 55%; 30-day mortality rates were 0e13%, 90-day rates 4e24%. Factors associated with increased odds of re-admission or death at 30 or 90 days included living alone, cognitive impairment, depression, NYHA classification, left atrial volume index, and Charlson index score. Nurse-led disease management programs and reviews within 7 days were associated with reduced odds of re-admission (but not of death) at 30 and 90 days; exercise programs were associated with reduced odds at 90 days. Significant between-hospital differences in re-admission rates were reduced after adjustment for post-discharge management programs, and abolished by further adjustment for echocardiography findings. Between-hospital differences in mortality were largely explained by differences in echocardiographic findings. Conclusions: Differences in early re-admission rates after hospitalisation for HF are primarily explained by differences in post-discharge management.
AB - Objectives: To investigate whether enrolment of patients in management programs after hospitalisation for heart failure (HF) reduces the likelihood of post-hospital adverse outcomes. Design: Cohort study in which associations between adverse outcomes at 30 and 90 days for people hospitalised for HF and baseline clinical, socio-demographic and blood pathology factors, and with post-discharge management strategies, were assessed. Setting, participants: 906 patients with HF were prospectively enrolled in five Australian states at cardiology departments with expertise in treating people with HF. Main outcome measures: All-cause re-admissions and deaths at 30 and 90 days after discharge from the index admission. Results: 58% of patients were men; the mean age was 72.5 years (SD, 13.9 years). By hospital, 30-day re-admission rates ranged from 17% to 33%, and 90-day rates from 40% to 55%; 30-day mortality rates were 0e13%, 90-day rates 4e24%. Factors associated with increased odds of re-admission or death at 30 or 90 days included living alone, cognitive impairment, depression, NYHA classification, left atrial volume index, and Charlson index score. Nurse-led disease management programs and reviews within 7 days were associated with reduced odds of re-admission (but not of death) at 30 and 90 days; exercise programs were associated with reduced odds at 90 days. Significant between-hospital differences in re-admission rates were reduced after adjustment for post-discharge management programs, and abolished by further adjustment for echocardiography findings. Between-hospital differences in mortality were largely explained by differences in echocardiographic findings. Conclusions: Differences in early re-admission rates after hospitalisation for HF are primarily explained by differences in post-discharge management.
KW - Continuity of patient care
KW - Delivery of health care
KW - Heart failure
KW - Managed care programs
UR - http://www.scopus.com/inward/record.url?scp=85049175065&partnerID=8YFLogxK
U2 - 10.5694/mja17.00809
DO - 10.5694/mja17.00809
M3 - Article
C2 - 29747565
AN - SCOPUS:85049175065
SN - 0025-729X
VL - 208
SP - 485
EP - 491
JO - The Medical journal of Australia
JF - The Medical journal of Australia
IS - 11
ER -